The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Lamotrigine and the risk of malformations in pregnancy
Abstract
OBJECTIVE: To report the frequency of major malformations in lamotrigine-exposed pregnancies from September 1, 1992, through March 31, 2004, in the International Lamotrigine Pregnancy Registry. METHODS: Health care professionals throughout the world can voluntarily enroll lamotrigine-exposed pregnancies in this observational study. Only pregnancies with unknown outcomes at the time of enrollment were included in the analysis. The percentage of outcomes with major birth defects was calculated as the total number of outcomes with major birth defects divided by the sum of the number of outcomes with major birth defects + the number of live births without defects. RESULTS: Among 414 first-trimester exposures to lamotrigine monotherapy, 12 outcomes with major birth defects were reported (2.9%, 95% CI 1.6% to 5.1%). Among the 88 first-trimester exposures to lamotrigine polytherapy including valproate, 11 outcomes with major birth defects were reported (12.5%; 95% CI 6.7% to 21.7%). Among 182 first-trimester exposures to lamotrigine polytherapy excluding valproate, 5 outcomes with major birth defects were reported (2.7%, 95% CI 1.0% to 6.6%). No distinctive pattern of major birth defects was apparent among the offspring exposed to lamotrigine monotherapy or polytherapy. CONCLUSIONS: The risk of all major birth defects after first-trimester exposure to lamotrigine monotherapy (2.9%) was similar to that in the general population and in other registries enrolling women exposed to antiepileptic monotherapy (3.3% to 4.5%). However, the sample size was too small to detect any but very large increases in specific birth defects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods for Rates and Proportions
Fleiss, J. L., Levin, B., & Paik, M. C. (2003) · Wiley Series in Probability and Statistics · doi:10.1002/0471445428 · Cited by 18,646
The Teratogenicity of Anticonvulsant Drugs
Holmes, L. B., Harvey, E. A., Coull, B. A., Huntington, K. B., Khoshbin, S., Hayes, A. M., & Ryan, L. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104123441504 · Cited by 655
Increased rate of major malformations in offspring exposed to valproate during pregnancy
Wyszynski, D. F., Nambisan, M., Surve, T., Alsdorf, R. M., Smith, C. R., & Holmes, L. B. (2005) · Neurology · doi:10.1212/01.wnl.0000154516.43630.c5 · Cited by 390
Congenital malformations due to antiepileptic drugs
Kaneko, S., Battino, D., Andermann, E., Wada, K., Kan, R., Takeda, A., Nakane, Y., Ogawa, Y., Avanzini, G., Fumarola, C., et al. (1999) · Epilepsy Research · doi:10.1016/s0920-1211(98)00084-9 · Cited by 374
Malformations Due to Presumed Spontaneous Mutations in Newborn Infants
Nelson, K., & Holmes, L. B. (1989) · New England Journal of Medicine · doi:10.1056/nejm198901053200104 · Cited by 302
Lamotrigine in Pregnancy: Pharmacokinetics During Delivery, in the Neonate, and During Lactation
Ohman, I., Vitols, S., & Tomson, T. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb00232.x · Cited by 295
ANTICONVULSANTS AND PARENTAL EPILEPSY IN THE DEVELOPMENT OF BIRTH DEFECTS
Shapiro, S., Hartz, S., Siskind, V., Mitchell, A., Slone, D., Rosenberg, L., Monson, R., Heinonen, O., Idänpàan-Heikkilä, J., Häró, S., et al. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91403-3 · Cited by 263
Reefhuis, J., & Honein, M. A. (2004) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20065 · Cited by 253
ANTICONVULSANTS AND PARENTAL EPILEPSY IN THE DEVELOPMENT OF BIRTH DEFECTS
SHAPIRO, S., SLONE, D., HARTZ, S. C., ROSENBERG, L., SISKIND, V., MONSON, R. R., MITCHELL, A. A., & HEINONEN, O. P. (1976) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-197608000-00012 · Cited by 245
Lamotrigine clearance during pregnancy
Tran, T. A., Leppik, I. E., Blesi, K., Sathanandan, S. T., & Remmel, R. (2002) · Neurology · doi:10.1212/wnl.59.2.251 · Cited by 241
Cited by
Morrow, J. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.074203 · Cited by 880
Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic Drugs
Meador, K. J., Baker, G. A., Browning, N., Clayton-Smith, J., Combs-Cantrell, D. T., Cohen, M., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803531 · Cited by 812
Duncan, J. S., Sander, J. W., Sisodiya, S. M., & Walker, M. C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68477-8 · Cited by 728
Meador, K., Reynolds, M. W., Crean, S., Fahrbach, K., & Probst, C. (2008) · Epilepsy Research · doi:10.1016/j.eplepsyres.2008.04.022 · Cited by 400
Seizure control and treatment in pregnancy: Observations from the EURAP Epilepsy Pregnancy Registry
The EURAP Study Group (2006) · Neurology · doi:10.1212/01.wnl.0000195888.51845.80 · Cited by 331
Metadata
- Authors
- Cunnington, M., Tennis, P., & the International Lamotrigine Pregnancy Registry Scientific Advisory Committee
- Venue
- Neurology
- Published
- 2005-03-22
- Volume
- 64
- Issue
- 6
- Pages
- 955-960
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2104683888
- Cited by
- 348
- References
- 29
- FWCI
- 23.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lamotrigine and the risk of malformations in pregnancy. https://app.cochat.ai/papers/10.1212/01.wnl.0000154515.94346.89
- The paper
- Cunnington, M., Tennis, P., & the International Lamotrigine Pregnancy Registry Scientific Advisory Committee. (2005). Lamotrigine and the risk of malformations in pregnancy. Neurology. https://doi.org/10.1212/01.wnl.0000154515.94346.89
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.